3Derm Announces Two FDA Breakthrough Device Designations for Autonomous Skin Cancer AI
DermSpot* is an algorithm that uses artificial intelligence (AI) and highly standardized skin images to autonomously detect melanoma, squamous cell carcinoma, and basal cell carcinoma.
DermSpot is being developed in collaboration with primary care physicians and dermatologists across the country.
We’re committed to using technology to increase access for all patients by focusing on high-impact disease areas and solutions
Our research prioritizes safety, efficacy, and equity.
No Automation Without Representation
We stand for technology that works for every skin tone.